GoldenGolden
Advanced Search
dievini Hopp Biotech Holding

dievini Hopp Biotech Holding

A German company that focuses on life and health sciences companies

dievini Hopp Biotech Holding is a German company that focuses on life and health sciences companies. Founded 2005 in Walldorf, Baden-Wurttemberg, Germany by Christof Hettich and Friedrich Bohlen, this private equity firm invests in late stage ventures. It usually invests in Series E, private equity rounds, Series F, and Series D rounds. Its portfolio companies include Novaliq, immatics biotechnologies, Molecular Health, CureVac, and AC Immune. The company focuses on innovative therapeutics and diagnostics on life-threatening diseases, such as in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. Dievini’s activities are geographically centered in Germany and Europe.

Timeline

2005
Founded

People

Name
Role
LinkedIn

Mathias Hothum

Managing Director

Christof Hettich

Co-Founder / Managing Director

Friedrich Bohlen

Managing Director

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

AC Immune

CureVac

immatics biotechnologies

Molecular Health

Novaliq

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.